{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:40:58Z","timestamp":1754152858443,"version":"3.41.2"},"reference-count":24,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:00:00Z","timestamp":1489536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background &amp; Aims<\/jats:title><jats:p>Adult studies of autoimmune hepatitis (<jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content>) have shown that the model of end\u2010stage liver disease is associated with resistance to first\u2010line treatment. Using a multicentre retrospective database, we sought to determine if the paediatric end\u2010stage liver disease (<jats:styled-content style=\"fixed-case\">PELD<\/jats:styled-content>) score would similarly predict treatment resistance in paediatric <jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One hundred and seventy\u2010one children from 13 Canadian centres who fulfilled the International Autoimmune Hepatitis Group (<jats:styled-content style=\"fixed-case\">IAIHG<\/jats:styled-content>) criteria were included and assessed for change to second\u2010line therapy within 24\u00a0months of primary treatment onset. Those with <jats:styled-content style=\"fixed-case\">PSC<\/jats:styled-content> overlap at presentation, or missing data on the <jats:styled-content style=\"fixed-case\">PELD<\/jats:styled-content> variables were excluded. <jats:styled-content style=\"fixed-case\">PELD<\/jats:styled-content> was calculated for all remaining patients. Univariate analysis and receiver\u2010operator characteristic (<jats:styled-content style=\"fixed-case\">ROC<\/jats:styled-content>) curves were performed to determine the predictive ability of the <jats:styled-content style=\"fixed-case\">PELD<\/jats:styled-content> score to change to second\u2010line therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 103 children were included with median age of 11\u00a0years (range 2\u201017). Mean <jats:styled-content style=\"fixed-case\">PELD<\/jats:styled-content> was \u22122.51\u00b18.58. Second\u2010line therapy was used within 24\u00a0months of diagnosis in 13 patients. Univariate analysis revealed that change to second\u2010line therapy was associated with higher <jats:styled-content style=\"fixed-case\">PELD<\/jats:styled-content> (<jats:italic>P<\/jats:italic>=.028) and internal normalized ratio (<jats:styled-content style=\"fixed-case\">INR<\/jats:styled-content>) (<jats:italic>P<\/jats:italic>=.011). <jats:styled-content style=\"fixed-case\">ROC<\/jats:styled-content> curves for <jats:styled-content style=\"fixed-case\">PELD<\/jats:styled-content> and its individual components were performed. The strength of association was strongest with <jats:styled-content style=\"fixed-case\">INR<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">AUC<\/jats:styled-content> 0.72; <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.58\u20100.86) although the composite <jats:styled-content style=\"fixed-case\">PELD<\/jats:styled-content> score also showed some predictive ability (<jats:styled-content style=\"fixed-case\">AUC<\/jats:styled-content> 0.67; <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.52\u20100.81).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this paediatric <jats:styled-content style=\"fixed-case\">AIH<\/jats:styled-content> cohort, higher <jats:styled-content style=\"fixed-case\">PELD<\/jats:styled-content> at presentation predicted change to second\u2010line therapy within the first 2\u00a0years of follow\u2010up. <jats:styled-content style=\"fixed-case\">INR<\/jats:styled-content> appeared to be the main contributor to that association.<\/jats:p><\/jats:sec>","DOI":"10.1111\/liv.13387","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T16:36:53Z","timestamp":1487176613000},"page":"1562-1570","source":"Crossref","is-referenced-by-count":1,"title":["A national retrospective study of paediatric end\u2010stage liver disease as a predictor of change to second\u2010line therapy in children with autoimmune hepatitis"],"prefix":"10.1111","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6350-2057","authenticated-orcid":false,"given":"Andr\u00e9anne N.","family":"Zizzo","sequence":"first","affiliation":[{"name":"Division of Gastroenterology Department of Paediatrics London Children's Hospital Western University  London ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Jimenez\u2010Rivera","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition Department of Paediatrics Children's Hospital of Eastern Ontario University of Ottawa  Ottawa ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine University Health Network, University of\u00a0Toronto  \u00a0Toronto ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Schreiber","sequence":"additional","affiliation":[{"name":"Division of Paediatric Gastroenterology, Hepatology and Nutrition Department of Paediatrics University of British Columbia  Vancouver BC Canada"},{"name":"Child and Family Research Institute  Vancouver BC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon C.","family":"Ling","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition The Hospital for Sick Children  Toronto ON Canada"},{"name":"Department of Paediatrics University of Toronto  Toronto ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Yap","sequence":"additional","affiliation":[{"name":"Division of Paediatric Gastroenterology and Nutrition Department of Paediatrics University of Alberta  Edmonton AB Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Critch","sequence":"additional","affiliation":[{"name":"Department of Paediatrics Faculty of Medicine Memorial University  St. John's NL Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najma","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Division of Paediatric Gastroenterology and Nutrition Montreal Children's Hospital McGill University  Montreal QC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition Department of Paediatrics H\u00f4pital Sainte\u2010Justine Universit\u00e9 de Montr\u00e9al  Montreal QC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binita M.","family":"Kamath","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition The Hospital for Sick Children  Toronto ON Canada"},{"name":"Department of Paediatrics University of Toronto  Toronto ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The Canadian Paediatric Hepatology Research Group (CPHRG)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"key":"e_1_2_9_2_1","first-page":"727A","article-title":"Incidence and characteristics of autoimmune hepatitis in children and adolescents in Canada: a preliminary report of The Canadian Pediatric Hepatology Research Group","volume":"56","author":"Jimenez\u2010Rivera C","year":"2012","journal-title":"Hepatology"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23584"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250308"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200207270-00006"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6135.2004.00403.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24141"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21787"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-0578"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2011.524206"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22131"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-7-199610010-00009"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.009"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10024-005-0020-0"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23294"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181a1c265"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cld.296"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01147.x"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000304456.84552.13"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21680"},{"key":"e_1_2_9_22_1","first-page":"3","article-title":"Laboratory evaluation of the patient with liver disease","volume":"8","author":"Astegiano M","year":"2004","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_9_23_1","first-page":"1","article-title":"Prothrombin time in patients with and without fibrotic chronic liver disease","volume":"8","author":"Sajjadieh M","year":"2008","journal-title":"Internet J Pathol"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1233529"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.13387","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.13387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T12:51:02Z","timestamp":1753188662000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.13387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1111\/liv.13387"],"URL":"https:\/\/doi.org\/10.1111\/liv.13387","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"type":"print","value":"1478-3223"},{"type":"electronic","value":"1478-3231"}],"subject":[],"published":{"date-parts":[[2017,3,15]]}}}